News | Robotic Systems | September 18, 2017

Corindus Announces First Patient Enrolled in PRECISION GRX Registry

Multicenter post-market registry designed to collect data on routine use of the CorPath GRX System

Corindus Announces First Patient Enrolled in PRECISION GRX Registry

September 18, 2017 — Corindus Vascular Robotics Inc. announced first patient enrollment in the PRECISION GRX Registry, a post-market study to continue market surveillance of the company's second-generation CorPath GRX System.

The PRECISION GRX Registry will include up to 25 sites and enroll up to 1,000 patients receiving robotic-assisted percutaneous coronary intervention (PCI). The study will gather data to evaluate patient outcomes, potential economic benefits, procedural parameters and the expanding capabilities of robotics in PCI. Additional sub-studies will seek to evaluate the impact of robotics on left transradial access and robotic wiring times. Ehtisham Mahmud, M.D., division chief of UC San Diego Health, cardiovascular medicine and medical director, Sulpizio Cardiovascular Center, has been named as the global principal investigator for the PRECISION GRX Study.

"We have shown that robotic-assisted PCI can be used with high clinical and technical success in multiple sites with multiple operators, and the new registry is designed to evaluate the impact of the expanding capabilities of robotics," said Mahmud. "I look forward to spearheading the effort in evaluating this new technology and its value in current practice."

The procedure on the first patient in the trial was performed by Srini Potluri, M.D., at The Heart Hospital Baylor Plano, one of two Baylor hospitals participating in the Registry. The hospital currently has two CorPath GRX Systems installed in its catheterization labs. Potluri stated, "I am excited to participate in the PRECISION GRX Registry to expand the depth of clinical research supporting robotic-assisted PCI. Our participation emphasizes our continuous commitment to advancing patient care in interventional medicine."

For more information: www.corindus.com

Related Content

Shockwave Initiates U.S. Pivotal Study for Coronary Intravascular Lithotripsy
News | Cath Lab | January 16, 2019
Shockwave Medical Inc. has initiated its U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE...
National Academy of Engineering, Ohio University Award 2019 Russ Prize
News | Cath Lab | January 03, 2019
Ohio University and the National Academy of Engineering announced the 2019 Fritz J. and Dolores H. Russ Prize will be...
Videos | Cath Lab | January 03, 2019
This is walk through inside one of the cardiac hybrid cath labs at the...
Videos | Cath Lab | January 03, 2019
This is the newest cardiac cath lab at the ...
Study Finds Effective Treatment for Coronary Slow Flow
News | Cath Lab | December 27, 2018
Patients who arrive at the hospital with heart-attack-like symptoms have had little recourse for their chest pain if...
Shockwave Announces Collaboration With Abiomed on Physician Training
News | Cath Lab | December 14, 2018
Shockwave Medical announced a new investment and collaboration agreement with Abiomed Inc. As outlined by the agreement...
Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Overlay Init